and are particularly problematic for reverse transcriptases (RTs), causing cDNA synthesis to stop or incorporate a wrong nucleotide. In mammals, N 1 -methyladenosine (m 1 A) is present in all tRNAs at position 58, N 3 -methylcytosine (m 3 C) is present in five tRNAs at position 32 and the variable loop, and N 1 -methylguanosine (m 1 G) is present in about half of all tRNAs at position 37 or 9. We applied two recombinant enzymes as a mixture to remove these three methylations in human tRNAs. The first was the wild-type enzyme AlkB from Escherichia coli, which is known to efficiently demethylate m 1 A and m 3 C in single-stranded nucleic acids as its DNA and RNA repair function 5, 6 . Wild-type AlkB, however, works very poorly on m 1 G modification 7 . On the basis of its known three-dimensional structure complexed with nucleic acids, we engineered AlkB to generate a specific mutant, D135S, that efficiently converted m 1 G to G (Supplementary Fig. 1a,b) . We optimized the reaction conditions and enzyme-to-RNA ratios using a mixture of the wild-type and the D135S AlkB proteins ( Supplementary Fig. 1c,d ). We were able to remove >80% of total m 1 A, m 3 C and ~70% m 1 G without a noticeable change in tRNA quality (Fig. 1b) . The remaining m 1 A or m 1 G may be buried deeper in the tRNA tertiary structure (m 1 A or m 1 G at position 9 of tRNAs) and thus not easily accessible to demethylase treatment without causing tRNA degradation.
Second, we used a thermostable group II intron reverse transcriptase (TGIRT; InGex) with high processivity to generate cDNA from highly structured tRNA. The TGIRT reaction does not require adaptor ligation; it synthesizes cDNA by templateswitching from the adaptor to the 3′ end of the target RNA [8] [9] [10] . Notably, demethylase treatment markedly reduced the amount of RT stops at the m 1 A58 and m 1 G37 positions. At the same time, the amount of longer and full-length cDNAs was substantially increased after demethylase treatment of tRNA (Fig. 1c) . Similar results regarding demethylase treatment were obtained when the RNA template was either total cellular RNA or gel-purified total tRNA (Fig. 1c) . These results show that the demethylase treatment was effective in producing longer reads; this property will be crucial for the ability to adequately map mammalian tRNA expression, where many tRNAs have just one or a handful of differences in their sequences 11, 12 .
We performed Illumina sequencing using the libraries generated from HEK293T tRNAs with and without the demethylase treatment. To facilitate our focus on tRNA at this time, we mapped the sequencing reads to only the genomic tRNA database, which contains 515 predicted tRNA genes distributed over 330 unique sequences and 110 predicted tRNA pseudogenes 12 despite its biological importance, trna has not been adequately sequenced by standard methods because of its abundant post-transcriptional modifications and stable structure, which interfere with cdna synthesis. We achieved efficient and quantitative trna sequencing in heK293t cells by using engineered demethylases to remove base methylations and a highly processive thermostable group ii intron reverse transcriptase to overcome these obstacles. our method, dm-trna-seq, should be applicable to investigations of trna in all organisms.
High-throughput RNA sequencing (RNA-seq) has revolutionized our understanding of gene expression. Widely used RNA-seq methods start with adaptor ligation and cDNA synthesis of biological RNA samples followed by PCR amplification to generate sequencing libraries 1 . These standard methods work well for most cellular RNAs such as mRNA, long noncoding RNA, microRNA, or fragments derived from rRNA, small nuclear RNA and small nucleolar RNA. tRNA is the only class of small cellular RNA for which the standard sequencing methods cannot yet be applied efficiently and quantitatively, although attempts have been made (for example, ref. 2). Significant obstacles for the sequencing of tRNA include the presence of numerous post-transcriptional modifications and its stable and extensive secondary structure, which interfere with cDNA synthesis and adaptor ligation. tRNAs are essential for cells, and their synthesis is under stringent cellular control. Recent evidence shows that tRNA expression and mutations are associated with various diseases such as neurological pathologies and cancer development 3, 4 . The lack of efficient and quantitative tRNA sequencing methods has hindered biological studies of tRNA.
We applied two strategies to eliminate or substantially reduce the obstacles of tRNA modification and structure for efficient and quantitative tRNA sequencing (Fig. 1a) . First, an enzyme mixture was used to remove methylations at the Watson-Crick face. Three specific modifications are abundant in eukaryotic tRNAs tRNA database when using gel-purified tRNA or total RNA as template, respectively (Supplementary Fig. 2a) . These variations in read numbers were derived from sample handling, as similar proportions of reads were obtained for the added internal tRNA standards (Supplementary Fig. 2b ). For the biological replicate from HEK293T cells, both untreated and treated samples showed similarly high reproducibility with r 2 values of 0.985-0.991 ( Supplementary  Fig. 3 ). As already indicated by the cDNA bands (Fig. 1c) , the read length and in particular the proportion of reads corresponding to full-length tRNA increased substantially after demethylase treatment, as shown by the position plots along individual tRNA genes (Fig. 2a,b) . The highest fraction of reads in a LeuAAG tRNA in the untreated samples were RT stops due to the m 1 G37 modification; after demethylase treatment, all stops at this position were removed and there was a corresponding increase of full-length tRNA reads (Fig. 2a) . 
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Similarly, after demethylase treatment, the substantial RT stop at m 1 G9 of a GlnCTG tRNA was markedly reduced, which occurred together with a substantially increased generation of full-length reads (Fig. 2b) . We still detected a strong stop at the m 2 2 G26 (N 2 ,N 2 -dimethylguanosine) residue in LeuAAG tRNA that remained unchanged upon demethylase treatment (Fig. 2a) . This result indicates that our demethylase mixture was not effective in removing m 2 2 G modifications, which are present in ~20% of tRNAs. Nevertheless, our results show that the demethylase treatment was very effective in producing longer reads; this property is crucial for the ability to adequately map the mammalian tRNAome at single-base resolution.
We performed additional analysis to further demonstrate the usefulness of our sequencing method. Plotting each tRNA isoacceptor against its gene copy number showed a poor correlation (Fig. 2c) , which is consistent with the known tissue-specific tRNA expression in humans 13, 14 . We compared the read fraction of the tRNA Arg isoacceptors to the fluorescence hybridization signals of the Arg-tRNA probes from tRNA microarrays that were obtained through hybridization without the need for cDNA synthesis 13, 15 . The sequencing and array results showed the same trend of isoacceptor abundance, thus validating the quantitative nature of tRNA abundance obtained independently through sequencingand hybridization-based approaches (Fig. 2d) . We also compared RT stops and misincorporations at known modification positions with and without demethylase treatment. In the case of m 1 A58 in ValCAC and m 3 C32 in ThrAGT, the demethylases completely removed these modifications as demonstrated by the reversion to cognate sequence at these positions (Fig. 2e,f) . In the case of m 1 G37 in ProTGG and m 1 G9 in GlnCTG, the demethylase treatment removed a large majority of the modification, so the mismatch and stops were substantially reduced (Fig. 2e,f) . Therefore, our DM-tRNA-seq (demethylase-thermostable group II intron RT tRNA sequencing) method can determine differences in the modification dynamics of m 1 A, m 1 G and m 3 C at single-base resolution, as well as potentially infer positions of nondemethylated modifications.
We also examined the expression of unique tRNA genes from chromosome 6. Human chromosome 6 contains approximately one-third of all tRNA genes, and over 150 genes are clustered within a 2.7-Mbp region near the class I major histocompatibility genes 16 . We found that the tRNA expression levels within the tRNA gene cluster were higher compared to those of tRNA genes outside of the cluster (Supplementary Fig. 4) . The expression level of tRNA genes in the cluster was uneven, suggesting that the expression of tRNA genes was not coordinated throughout the entire cluster in HEK293T cells.
Our approach described here makes efficient and quantitative tRNA sequencing feasible and has an additional advantage of being able to study modifications in a high-throughput manner. Supplementary Fig. 1a) . We reasoned that single mutants at the D135 position might allow better accommodation of m 1 G in the active site ( Supplementary  Fig. 1a) , thereby enhancing the demethylation efficiency of m 1 G. Truncated but catalytically active AlkB-∆N11 was used, and mutants with single-amino-acid replacement at D135 were screened. Of several mutations tested, AlkB D135S gave the best demethylation yields toward m 1 G (Supplementary Fig. 1b) . In the AlkB-m 1 G structure model constructed by computationally mutating the AlkB structure (Supplementary Fig. 1a) , the shorter side chain of S135 seems to allow more room to accommodate m 1 G while sustaining the crucial hydrogen bond with m 1 G, which may explain the improvement in activity.
We also performed pH-activity profiling for the demethylation of m 1 A and m 1 G in tRNA. Decreasing demethylation activity was observed with increasing pH for both m 1 A and m 1 G substrates (Supplementary Fig. 1c) . Therefore, we chose pH 5.0 for detailed kinetic analysis and subsequent experiments.
Cloning, expression and purification of wild-type and mutant AlkB. A truncated AlkB with deletion of the amino (N)-terminal 11 amino acids was cloned into a pET30a vector (Novagen) and overexpressed in E. coli BL21(DE3) 18 . The proteins were purified following procedures published previously 19 . Briefly, cells were grown at 37 °C in the presence of 50 µM kanamycin until the OD 600 reached 0.6-0.8. After the addition of IPTG (1 mM) and FeSO 4 (5 µM), the cells were incubated for an additional 4 h at 30 °C. Cells were collected, pelleted and then resuspended in lysis buffer (10 mM Tris, pH 7.4, 300 mM NaCl, 5% glycerol, 2 mM CaCl 2 , 10 mM MgCl 2 , 10 mM 2-mercaptoethanol). The cells were lysed by sonication and then centrifuged at 17,418g for 20 min. The soluble proteins were first purified using a Ni-NTA superflow cartridge (Qiagen) and then further purified by ion-exchange (Mono S GL, GE Healthcare) and gel-filtration (Superdex-200, Pharmacia) chromatography. All protein purification steps were performed at 4 °C. The Asp-to-Ser mutation was introduced using the QuikChange Site-Directed Mutagenesis Kit (Agilent). The mutant protein was expressed and purified following the same procedure as that for the wild-type protein.
Mammalian cell culture and RNA preparations. Human embryonic kidney HEK293T (CRL-11268) cells were obtained from the American Type Culture Collection (ATCC) and used without further validation. Cells were cultured in DMEM (Thermo) medium supplemented with 10% FBS and 1% 100× penicillin-streptomycin (Gibco). Cells were routinely checked for mycoplasma contamination every 3-6 months using the Universal Mycoplasma Detection Kit (ATCC).
Total RNA was isolated by using a mirVana miRNA Isolation Kit (Life Technologies). Purified total RNA was premixed with the T7 RNA polymerase transcripts of three tRNA standards 13 (0.01 pmol each standard per µg of total RNA) and deacylated by incubating in 0.1 M Tris-HCl, pH 9, at 37 °C for 45 min. Although not necessary for studies of mature tRNAs, which all end with 3′ CCA, deacylated RNAs with or without demethylation treatment could be treated with T4 polynucleotide kinase (Epicentre) at 37 °C for 30 min to further warrant a free 3′ hydroxyl group for template-switching.
When necessary, total tRNA was subsequently isolated using a denaturing 10% polyacrylamide gel followed by passive gel elution and ethanol precipitation.
Demethylation reactions. The demethylation activity assay was performed for either gel-purified total tRNA or total cellular RNA. For total tRNA, 100 µl of reaction mixture containing 1 µg of tRNA (~40 pmol) were treated with 2× molar ratio of wtAlkB (80 pmol) and 4× molar ratio of D135S mutant (160 pmol). For total cellular RNA, 5 µg of total RNA (estimated to contain ~40 pmol tRNA) were treated with 4× molar ratio of wtAlkB (160 pmol) and 5× molar ratio of D135S (200 pmol). More demethylases were used for total RNA to alleviate potential interference by rRNA and mRNA in the reaction. The reaction buffer contained 300 mM KCl, 2 mM MgCl 2 , 50 µM of (NH 4 ) 2 Fe(SO 4 ) 2 ·6H 2 O, 300 µM 2-ketoglutarate (2-KG), 2 mM l-ascorbic acid, 50 µg/ml BSA, 50 mM MES buffer (pH 5.0). In both cases, the reaction was incubated for 2 h at room temperature and quenched by the addition of 5 mM EDTA. After phenol-chloroform extraction, tRNA was recovered by ethanol precipitation.
Thermostable group II intron RT template-switching. Templateswitching reactions were performed as described [8] [9] [10] . Briefly, we used an initial template-primer substrate consisting of a 41-nt RNA oligonucleotide (5′-AGA UCG GAA GAG CAC ACG UCU AGU UCU ACA GUC CGA CGA UC/3SpC3/-3′) that contains Illumina Read1 and Read2 primer-binding sites and a 3′ blocking group (three-carbon spacer; Integrated DNA Technologies, Inc.) annealed to a complementary 32 P-labeled DNA primer with a single-nucleotide 3′ overhang, T, which facilitates the template switch to full-length tRNAs that mostly contain a 3′ CCA end. For TGIRT template-switching reactions, typically 100 ng of demethylated tRNAs or 1 µg of demethylated total RNA were mixed with the initial template-primer substrate (100 nM) and 500 nM TGIRT (GsI-IIC MalE rigid fusion RT 10 ) in reaction medium containing 450 mM NaCl, 5 mM MgCl 2 , 20 mM Tris-HCl, pH 7.5, and 5 mM DTT. The reactions were preincubated at room temperature for 30 min, initiated by adding 25 mM dNTPs (an equimolar mix of 25 mM dATP, dCTP, dGTP and dTTP) to a final concentration of 1 mM and incubating at 60 °C for 30 min. The reactions were terminated by adding 5 M NaOH to a final concentration of 0.25 M, incubating at 95 °C for 3 min and neutralizing with 5 M HCl. The cDNAs resulting from templateswitching were analyzed in a denaturing 6% polyacrylamide gel, electroeluted using a D-tube Dialyzer Maxi with MWCO of 6-8 kDa (EMD Millipore) and ethanol precipitated with 0.3 M sodium acetate, pH 5.2, in the presence of 25 µg of linear acrylamide (Life Technologies) carrier. The purified cDNAs were then circularized with CircLigase II (Epicentre) using the manufacturer's protocol with an extended incubation time of 5 h at 60 °C, extracted with phenol-chloroform-isoamyl alcohol (25:24:1), ethanol precipitated and amplified with Phusion-HF (Thermo Scientific) using Illumina multiplex (5′-AAT GAT ACG GCG ACC ACC GAG ATC TAC ACG TTC AGA GTT CTA CAG TCC npg nature methods GAC GAT C-3′) and barcode (5′-CAA GCA GAA GAC GGC ATA CGA GAT BARCODE GTG ACT GGA GTT CAG ACG TGT GCT CTT CCG ATC T-3′) primers for 12 cycles of 98 °C for 5 s, 60 °C for 10 s and 72 °C for 10 s. The PCR products were sequenced on an Illumina HiSeq system.
Quantitative analysis of modification levels using LC-MS/MS.
Quantitative analysis of modified nucleotides was done as previously described 20 . Briefly, 100 ng of tRNA were digested by nuclease P1 (2 U) in 30 µl of buffer containing 25 mM NaCl and 2.5 mM ZnCl 2 at 37 °C for 1 h, followed by the addition of NH 4 HCO 3 (100 mM) and alkaline phosphatase (0.5 U). After an additional incubation at 37 °C for 1 h, the solution was diluted to 60 µl, and 10 µl of the solution were injected for LC-MS/MS. Nucleosides were separated by reversed-phase ultraperformance liquid chromatography on a C18 column with on-line mass spectrometry detection using an Agilent 6410 QQQ triple quadrupole LC mass spectrometer in positive electrospray ionization mode. The nucleosides were quantified using the nucleoside-to-base ion mass tran- tRNA microarrays. The tRNA microarray assay consists of four steps starting from purified tRNA or total RNA without the need of cDNA synthesis: (i) deacylation to remove all 3′-attached amino acids, (ii) selective fluorophore labeling of tRNA using oligonucleotide ligation with T4 DNA ligase to the 3′ CCA of all tRNAs, (iii) hybridization and (iv) data analysis. The reproducibility of the tRNA microarray method and validation of the results have been extensively described previously 13, 15 .
Sequencing read mapping. Sequencing reads were aligned using Bowtie to a modified hg19 genomic tRNA database 12 . A single mismatch was allowed in order to identify potential modification misincorporations at a modification site. Briefly, a tRNA library was adapted from the tRNAScan-SE library by appending CCA to tRNAs from the genomic tRNA database (http://gtrnadb.ucsc. edu/Hsapi19/). Isodecoders with identical scores were consolidated for ease of identity assignment, decreasing the number of reference genes and pseudogenes from 625 to 462. Prior to mapping, reads were processed using Trimmomatic v0.32. Sequences greater than 15 bp were then aligned to the aforementioned culled tRNA library using Bowtie2 with sensitive options. Reads mapping to multiple isodecoders owing to length of fragment were discarded. Modification fractions were determined by analyzing at a putative position n the number of correct reads, the number of misincorporations, as well as the number of reads stopped at the n + 1 position.
